NewLink Genetics Corporation - Product Pipeline Review - 2016

  • ID: 3734744
  • Company Profile
  • 53 pages
  • Global Markets Direct
1 of 4
NewLink Genetics Corporation - Product Pipeline Review - 2016

Summary

‘NewLink Genetics Corporation - Product Pipeline Review - 2016’, provides an overview of the NewLink Genetics Corporation’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by NewLink Genetics Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of NewLink Genetics Corporation
- The report provides overview of NewLink Genetics Corporation including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses NewLink Genetics Corporation’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features NewLink Genetics Corporation’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate NewLink Genetics Corporation’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for NewLink Genetics Corporation
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding NewLink Genetics Corporation’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

NewLink Genetics Corporation Snapshot

NewLink Genetics Corporation Overview

Key Information

Key Facts

NewLink Genetics Corporation - Research and Development Overview

Key Therapeutic Areas

NewLink Genetics Corporation - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

NewLink Genetics Corporation - Pipeline Products Glance

NewLink Genetics Corporation - Late Stage Pipeline Products

Phase III Products/Combination Treatment Modalities

NewLink Genetics Corporation - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

NewLink Genetics Corporation - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

NewLink Genetics Corporation - Drug Profiles

algenpantucel-L

Product Description

Mechanism of Action

R&D Progress

indoximod

Product Description

Mechanism of Action

R&D Progress

tergenpumatucel-L

Product Description

Mechanism of Action

R&D Progress

dorgenmeltucel-L

Product Description

Mechanism of Action

R&D Progress

Cellular Immunotherapy for Hormone Refractory Prostate Cancer

Product Description

Mechanism of Action

R&D Progress

Cellular Immunotherapy for Metastatic Renal Cell Carcinoma

Product Description

Mechanism of Action

R&D Progress

influenza [strain A/H5N1] vaccine

Product Description

Mechanism of Action

R&D Progress

influenza [strain A/H7N9] vaccine

Product Description

Mechanism of Action

R&D Progress

influenza [strain H1N1] vaccine

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit IDO and TDO for Cancer

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit TDO for Cancer

Product Description

Mechanism of Action

R&D Progress

(arenavirus + yellow fever) vaccine

Product Description

Mechanism of Action

R&D Progress

Zika virus vaccine

Product Description

Mechanism of Action

R&D Progress

NewLink Genetics Corporation - Pipeline Analysis

NewLink Genetics Corporation - Pipeline Products by Target

NewLink Genetics Corporation - Pipeline Products by Route of Administration

NewLink Genetics Corporation - Pipeline Products by Molecule Type

NewLink Genetics Corporation - Pipeline Products by Mechanism of Action

NewLink Genetics Corporation - Recent Pipeline Updates

NewLink Genetics Corporation - Dormant Projects

NewLink Genetics Corporation - Company Statement

NewLink Genetics Corporation - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

NewLink Genetics Corporation, Key Information

NewLink Genetics Corporation, Key Facts

NewLink Genetics Corporation - Pipeline by Indication, 2016

NewLink Genetics Corporation - Pipeline by Stage of Development, 2016

NewLink Genetics Corporation - Monotherapy Products in Pipeline, 2016

NewLink Genetics Corporation - Combination Treatment Modalities in Pipeline, 2016

NewLink Genetics Corporation - Out-Licensed Products in Pipeline, 2016

NewLink Genetics Corporation - Out-Licensed Products/ Combination Treatment Modalities, 2016

NewLink Genetics Corporation - Phase III, 2016

NewLink Genetics Corporation - Phase II, 2016

NewLink Genetics Corporation - Phase I, 2016

NewLink Genetics Corporation - Preclinical, 2016

NewLink Genetics Corporation - Discovery, 2016

NewLink Genetics Corporation - Pipeline by Target, 2016

NewLink Genetics Corporation - Pipeline by Route of Administration, 2016

NewLink Genetics Corporation - Pipeline by Molecule Type, 2016

NewLink Genetics Corporation - Pipeline Products by Mechanism of Action, 2016

NewLink Genetics Corporation - Recent Pipeline Updates, 2016

NewLink Genetics Corporation - Dormant Developmental Projects,2016

NewLink Genetics Corporation, Other Locations

NewLink Genetics Corporation, Subsidiaries

List of Figures

NewLink Genetics Corporation - Pipeline by Top 10 Indication, 2016

NewLink Genetics Corporation - Pipeline by Stage of Development, 2016

NewLink Genetics Corporation - Monotherapy Products in Pipeline, 2016

NewLink Genetics Corporation - Out-Licensed Products in Pipeline, 2016

NewLink Genetics Corporation - Pipeline by Target, 2016

NewLink Genetics Corporation - Pipeline by Route of Administration, 2016

NewLink Genetics Corporation - Pipeline by Molecule Type, 2016

NewLink Genetics Corporation - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll